Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.10 | 0.10 | 0.00 |
Shares | 99.85 | 99.85 | 0.00 |
Preferred | 0.06 | 0.06 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 19.97 | 19.66 |
Price to Book | 5.68 | 4.55 |
Price to Sales | 2.64 | 2.64 |
Price to Cash Flow | 18.64 | 17.59 |
Dividend Yield | 1.50 | 1.06 |
5 Years Earnings Growth | 10.82 | 13.85 |
Number of long holdings: 49
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 9.36 | 811.08 | -1.48% | |
UnitedHealth | US91324P1021 | 8.69 | 542.49 | -0.56% | |
Novo Nordisk B | DK0062498333 | 6.03 | 607.3 | +0.60% | |
AbbVie | US00287Y1091 | 5.41 | 183.90 | +4.70% | |
Intuitive Surgical | US46120E6023 | 4.11 | 571.88 | -1.43% | |
AstraZeneca | GB0009895292 | 4.09 | 11,344.0 | +0.27% | |
Thermo Fisher Scientific | US8835561023 | 3.63 | 597.75 | -1.48% | |
Roche Holding Participation | CH0012032048 | 3.57 | 286.00 | +0.28% | |
Bristol-Myers Squibb | US1101221083 | 3.53 | 58.95 | -0.32% | |
J&J | US4781601046 | 3.47 | 152.15 | -0.47% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Eaton Vance Atlanta Capital SMID I | 7.81B | 13.62 | 5.71 | 12.02 | ||
Eaton Vance Atlanta Capital SMID R6 | 5.59B | 13.70 | 5.78 | 12.11 | ||
Eaton Vance National Municipal IncI | 3.34B | 2.20 | -0.12 | 2.87 | ||
Eaton Vance Tx-Mgd Growth 1.1 A | 2.25B | 25.16 | 8.64 | 12.59 | ||
Eaton Vance Tx-Mgd Growth 1.0 | 1.45B | 25.45 | 8.92 | 12.92 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review